Contracts › 75N94025F00002
75N94025F00002: Nichd: R&D: Supporting the Phase Iib Clinical Trial of Subcutaneous Levonorgestrel Butanoate (LB) for Female Contraception: Non-Severable
Awarded to Health Decisions, Inc. by National Institutes of Health (NIH).
$1.3Mobligated
$2.4Mpotential value
31 March 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N94025F00002 |
|---|---|
| Vehicle | 75N94019D00004 |
| Awardee | Health Decisions, Inc. |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NICHD |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | NC |
| Period of performance | 01 August 2025 to 31 March 2028 |
| Potential end | 31 December 2028 |
| Estimated recompete solicitation | ~Q4 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record